Literature DB >> 17298591

Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy.

J Lopez-Bastida1, F Cabrera-Lopez, P Serrano-Aguilar.   

Abstract

AIMS: To assess the effectiveness of a non-mydriatic digital camera (45 degrees -30 degrees photographs) compared with the reference method for screening diabetic retinopathy.
METHODS: Type 1 and 2 diabetic patients (n = 773; 1546 eyes) underwent screening for diabetic retinopathy in a prospective observational study. Hospital-based non-mydriatic digital retinal imaging by a consultant specialist in retinal diseases was compared with slit-lamp biomicroscopy and indirect ophthalmoscopy through dilated pupils, as a gold standard, previously performed in a community health centre by another consultant specialist in retinal diseases. The main outcome measures were sensitivity and specificity of screening methods and prevalence of diabetic retinopathy.
RESULTS: The prevalence of any form of diabetic retinopathy was 42.4% (n = 328); the prevalence of sight-threatening including macular oedema and proliferative retinopathy was 9.6% (n = 74). Sensitivity of detection of any diabetic retinopathy by digital imaging was 92% (95% confidence interval 90, 94). Specificity of detection of any diabetic retinopathy was 96% (95, 98). The predictive value of the negative tests was 94% and of a positive test 95%. For sight-threatening retinopathy digital imaging had a sensitivity of 100%.
CONCLUSIONS: A high sensitivity and specificity are essential for an effective screening programme. These results confirm digital retinal imaging with a non-mydriatic camera as an effective option in community-based screening programmes for diabetic retinopathy.

Entities:  

Mesh:

Year:  2007        PMID: 17298591     DOI: 10.1111/j.1464-5491.2007.02074.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Comparison of image-assisted versus traditional fundus examination.

Authors:  Kristen Brown; Jeanette M Sewell; Clement Trempe; Tunde Peto; Thomas G Travison
Journal:  Eye Brain       Date:  2013-02-13

2.  [Fundus screening by medical technicians].

Authors:  F Schütt; T Bruckner; K Schäfer; D Lehnhoff; G Rudofsky; C Kasperk; P Nawroth; G U Auffarth
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

3.  Retinopathy screening in patients with type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging.

Authors:  N Minuto; V Emmanuele; M Vannati; C Russo; C Rebora; S Panarello; A Pistorio; R Lorini; G d'Annunzio
Journal:  J Endocrinol Invest       Date:  2011-10-06       Impact factor: 4.256

4.  Ultra-wide field imaging system and traditional retinal examinations for screening fundus changes after cataract surgery.

Authors:  Jie Peng; Qi Zhang; Hai-Ying Jin; Wu-Yi Lu; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

5.  Sensitivity and specificity of nonmydriatic digital imaging in screening diabetic retinopathy in Indian eyes.

Authors:  Vishali Gupta; Reema Bansal; Amod Gupta; Anil Bhansali
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

6.  The durability of sitagliptin in elderly patients with type 2 diabetes.

Authors:  Ching-Jung Hsieh; Feng-Chih Shen
Journal:  Clin Interv Aging       Date:  2014-11-07       Impact factor: 4.458

7.  Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography.

Authors:  Marcus Kernt; Indrawati Hadi; Florian Pinter; Florian Seidensticker; Christoph Hirneiss; Christos Haritoglou; Anselm Kampik; Michael W Ulbig; Aljoscha S Neubauer
Journal:  Diabetes Care       Date:  2012-08-21       Impact factor: 19.112

8.  Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?

Authors:  Daniel Chalk; Martin Pitt; Bijay Vaidya; Ken Stein
Journal:  Diabetes Care       Date:  2012-05-07       Impact factor: 19.112

9.  Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes.

Authors:  Antonio Rodríguez-Poncelas; Xavier Mundet-Tudurí; Sonia Miravet-Jiménez; Aina Casellas; Joan F Barrot-De la Puente; Josep Franch-Nadal; Gabriel Coll-de Tuero
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

10.  Telemedicine for diabetic retinopathy screening using an ultra-widefield fundus camera.

Authors:  Nazimul Hussain; Maryam Edraki; Rima Tahhan; Nishanth Sanalkumar; Sami Kenz; Nagwa Khalil Akasha; Brian Mtemererwa; Nahed Mohammed
Journal:  Clin Ophthalmol       Date:  2017-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.